|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/495 | |
| A61P 25/18 |
| (11) | Patento numeris | 1333832 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 01983555.2 |
| Europos patento paraiškos padavimo data | 2001-10-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2003-08-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-11-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2001/011952 |
| Data | 2001-10-16 |
| (87) | Numeris | WO 2002/040024 |
| Data | 2002-05-23 |
| (30) | Numeris | Data | Šalis |
| 00124815 | 2000-11-14 | EP |
| (72) |
BARTOSZYK, Gerd, DE
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | NOVEL USES OF COMBINED 5-HT1A AGONISTS AND SEROTONIN REUPTAKE INHIBITORS |
| NOVEL USES OF COMBINED 5-HT1A AGONISTS AND SEROTONIN REUPTAKE INHIBITORS |